We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Fischer and iCAD to Cooperate on CAD Mammography

By HospiMedica staff writers
Posted on 22 Jan 2003
Print article
An agreement to cooperate in adapting the computer-aided detection (CAD) technology of iCAD, Inc. (Hudson, NH, USA) for use in the analysis of the mammograms produced by the SenoScan digital mammography system of Fischer Imaging Corp. (Denver, CO, USA) was announced by the two companies at the annual meeting of the Radiological Society of North America (RSNA) in Chicago (IL, USA).

Under the agreement, Fischer will have worldwide exclusive rights to market this specialized iCAD software, designed to assist radiologists in identifying cancers that might otherwise be overlooked in routine mammography screening. Computer-aided detection from iCAD has been shown to detect 23% of breast cancers an average of 14 months earlier than screening mammography. ICAD says it is the fastest system available, is the only system to look for asymmetries, and is the most effective system available to detect breast masses.

"The SenoScan's industry-leading resolution of 50 microns in screening mode and 25 microns in diagnostic mode make it the ideal platform for iCAD's technology. We look forward to the results of this collaborative effort,” said Gerald D. Knudson, CEO of Fischer Imaging.





Related Links:
ICAD
Fischer Imaging
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Ambulatory Blood Pressure Monitor
ASPEL 308-508 ABPM
New
Mobile Patient Lift
Golvo 9000

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.